KWEB vs XBI
KraneShares CSI China Internet ETF vs SPDR S&P Biotech ETF
- • XBI has the lower expense ratio at 0.35% vs 0.69% for KWEB.
- • KWEB pays a higher dividend yield (9.23%).
Side-by-side metrics
| Metric | KWEB | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.69% | 0.35% |
Dividend yield Trailing 12-month yield. | 9.23% | 0.35% |
AUM Assets under management — bigger funds are typically more liquid. | $4.22B | $10.92B |
YTD return | -28.60% | 28.80% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.75 | 1.01 |
P/E ratio | 13.09 | — |
Last price | $23.71 | $156.41 |
Inception | — | — |
Issuer | KraneShares | State Street |
KWEB top holdings
| 0700.HK | Tencent Holdings Ltd | 9.92% |
| PDD | PDD Holdings Inc ADR | 8.68% |
| 9988.HK | Alibaba Group Holding Ltd Ordinary Shares | 8.63% |
| 3690.HK | Meituan Class B | 7.53% |
| 9999.HK | NetEase Inc Ordinary Shares | 6.64% |
| 2423.HK | KE Holdings Inc Class A | 5.01% |
| 9618.HK | JD.com Inc Ordinary Shares - Class A | 4.22% |
| 0992.HK | Lenovo Group Ltd | 4.00% |
| 9961.HK | Trip.com Group Ltd | 3.80% |
| YMM | Full Truck Alliance Co Ltd ADR | 3.15% |
XBI top holdings
| MRNA | Moderna Inc | 2.37% |
| NTRA | Natera Inc | 1.82% |
| HALO | Halozyme Therapeutics Inc | 1.77% |
| TWST | Twist Bioscience Corp | 1.77% |
| BIIB | Biogen Inc | 1.75% |
| AMGN | Amgen Inc | 1.73% |
| EXEL | Exelixis Inc | 1.73% |
| UTHR | United Therapeutics Corp | 1.72% |
| ABBV | AbbVie Inc | 1.71% |
| GILD | Gilead Sciences Inc | 1.70% |
About KWEB
KWEB (KraneShares CSI China Internet ETF) is Chinese internet and e-commerce companies. Managed by KraneShares, the fund carries $4.2B in assets under management, an expense ratio of 0.69%, a dividend yield of 9.23%. Its largest holding is Tencent Holdings Ltd (0700.HK), which represents 9.9% of the portfolio. Real Estate is the fund's largest sector exposure at 5.0%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.9B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.35%. Its largest holding is Moderna Inc (MRNA), which represents 2.4% of the portfolio. Financial Services is the fund's largest sector exposure at 0.6%.